An interventional study of The video-based exercise (VBE) and The standard exercise (SE) in Degenerative Disease, Meniscus Tear and Knee Pain Swelling, sponsored by Istanbul University - Cerrahpasa. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-11-21.
Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Treatment
This randomized controlled trial aims to investigate the efficacy of the video-based exercise programs in patients with degenerative meniscus tears.
To investigate the efficacy of video-based exercise programs, voluntary patients with degenerative meniscus tears aged 40-65 years will be randomly assigned to three groups: the hybrid exercise group (HEG), the video-based exercise (VBE) group, and the standard exercise (SE) group. Interventions will be delivered over 16 sessions (twice a week for 8 weeks). The patients will be assessed at baseline and at the end of the 8-week intervention. Pain during activity, at rest, and at night will be assessed using the Visual Analog Scale (VAS). Active range of motion will be evaluated using a digital goniometer. Isometric muscle strength will be measured with a handheld dynamometer. The Knee Injury and Osteoarthritis Outcome Score (KOOS) will evaluate functional status and symptoms. The Western Ontario Meniscal Evaluation Tool (WOMET) will assess health-related quality of life. Adherence to the exercise program and the Global Rating of Change Scale will be evaluated.
Istanbul University - Cerrahpasa is the lead sponsor of 680 studies on the registry; 208 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Each subject in the video-based exercise group (only video-based intervention) will receive a treatment protocol consisting of stretching, strengthening, and functional exercises for the knee and hip.
Other: The video-based exercise (VBE)
Each subject in the standard exercise group (only clinic-based intervention) will receive a treatment protocol consisting of stretching, strengthening, and functional exercises for the knee and hip.
Other: The standard exercise (SE)
Each subject in the hybrid exercise group (video-based and clinical-based interventions) will receive a treatment protocol consisting of stretching, strengthening, and functional exercises for the knee and hip.
Other: The hybrid exercise (HE)
An 8-week exercise program will be implemented as part of the conservative treatment for degenerative meniscal tears. The physiotherapist will prepare an instructional video that provides a detailed explanation and demonstration of each exercise. Patients will watch this video at home and perform the exercises according to the video instructions.
An 8-week exercise program used in conservative treatment of degenerative meniscus tears will be performed. An exercise program will be performed at the clinic.
An 8-week exercise program will be implemented as part of the conservative treatment for degenerative meniscal tears using a hybrid telerehabilitation model. For the home-based component, the physiotherapist will prepare an instructional video that includes a detailed description and demonstration of each exercise. Patients will watch this video at home and perform the prescribed exercises by following the instructions provided in the video. In addition to the home program, patients will also participate in supervised exercise sessions conducted in the clinical setting.
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Short-term and long-term symptoms and function will be assessed with the Knee injury and Osteoarthritis Outcome Score (KOOS) that is developed as an extension of the WOMAC Osteoarthritis Index. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.
Time frame: Baseline
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Short-term and long-term symptoms and function will be assessed with the Knee injury and Osteoarthritis Outcome Score (KOOS) that is developed as an extension of the WOMAC Osteoarthritis Index. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.
Time frame: At the end of 8-week intervention
Visual Analogue Scale (VAS)
Pain intensity will be measured using the visual analogue scale (VAS). The participants will be asked to indicate their perceived pain at rest, during activity and at night on the 10 cm line between no pain and terrible pain. The score will be determined by measuring the distance on 10 cm line using a ruler. The higher scores indicate an higher level of pain.
Time frame: Baseline
Visual Analogue Scale (VAS)
Pain intensity will be measured using the visual analogue scale (VAS). The participants will be asked to indicate their perceived pain at rest, during activity and at night on the 10 cm line between no pain and terrible pain. The score will be determined by measuring the distance on 10 cm line using a ruler. The higher scores indicate an higher level of pain.
Time frame: After 8-week intervention
Active Range of Motion
Active knee range of motion including flexion and extension will be measured described by the American Academy of Orthopaedic Surgeons (AAOS) using a digital goniometer.
Time frame: Baseline
Active Range of Motion
Active knee range of motion including flexion and extension will be measured described by the American Academy of Orthopaedic Surgeons (AAOS) using a digital goniometer.
Time frame: At the end of 8-week intervention
Muscle Strength
Isometric muscle strength will be measured with a handheld dynamometer for knee flexors and extensors. The process will be repeated three times in each direction, with the average value recorded.
Time frame: Baseline
Muscle Strength
Isometric muscle strength will be measured with a handheld dynamometer for knee flexors and extensors. The process will be repeated three times in each direction, with the average value recorded.
Time frame: At the end of the 8-week intervention
Western Ontario Meniscal Evaluation Tool (WOMET)
The health-related quality of life related to degenerative meniscal tear will be used with the WOMET, which is a disease-specific tool designed to evaluate health-related quality of life in patients with meniscal pathology. The WOMET contains sixteen items addressing three domains: nine items addressing physical symptoms; four items addressing disabilities due to sports, recreation, work, and lifestyle; and three items addressing emotions. The best and least symptomatic score is 0, and the highest and most symptomatic score possible is 1600.
Time frame: Baseline
Western Ontario Meniscal Evaluation Tool (WOMET)
The health-related quality of life related to degenerative meniscal tear will be used with the WOMET, which is a disease-specific tool designed to evaluate health-related quality of life in patients with meniscal pathology. The WOMET contains sixteen items addressing three domains: nine items addressing physical symptoms; four items addressing disabilities due to sports, recreation, work, and lifestyle; and three items addressing emotions. The best and least symptomatic score is 0, and the highest and most symptomatic score possible is 1600.
Time frame: At the end of the 8-week intervention
Global Rating of Change
The Global Rating of Change is a single-item self-report measure used to assess the participant's perceived overall change following the intervention. At the end of the 8-week intervention, participants will be asked to rate how their current condition compares to their condition before the treatment.
Time frame: At the end of 8-week intervention
Adherence to Exercise Programs
Adherence to the video-based exercise program will be monitored using daily participant-completed exercise logs and verified by weekly video submissions demonstrating the performance of selected exercises. The physiotherapist will directly monitor adherence to the clinic-based exercise program.
Time frame: Throughout the 8-week intervention period
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul University - Cerrahpasa